{
  "id": 3871,
  "text": "1923.Seamon, L.G., Downey, G.O., Harrison, C.R., Doss, B.& Carlson, J.W.Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1923.Seamon, L.G., Downey, G.O., Harrison, C.R., Doss, B.& Carlson, J.W.Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于孕期被诊断为IIIB期玻璃细胞宫颈癌的患者，治疗策略需要充分平衡疾病控制和胎儿健康。以下为需要综合考虑的治疗选项：\n\n1. **新辅助化疗**：在孕期进行低毒性的化疗方案，有助于控制肿瘤的进展，帮助部分患者延长妊娠至胎儿成熟。此方法在某些案例中显示出令人鼓舞的结果。\n\n2. **延迟治疗至分娩后**：如果患者肿瘤进展缓慢且妊娠已接近足月，可以考虑延迟进行全面治疗，等到分娩后再开展化疗和放疗。\n\n3. **剖宫产后全身治疗**：若妊娠早期即可进行剖宫产分娩后立刻开展化疗联合放疗，以尽早控制癌症。\n\n4. **多学科团队管理**：包括妇科肿瘤学家、产科医生、新生儿科医生和放化疗专家的联合会诊，综合评估疾病阶段和妊娠周数，个体化选择治疗路径。\n\n这些选择需根据患者的具体病情、肿瘤位置、胎儿发育状态、患者意愿以及多学科团队的专业建议制定，确保在尽可能控制母亲疾病的基础上保护胎儿健康。",
  "query": "在孕期被诊断为IIIB期玻璃细胞宫颈癌的患者应该考虑哪些治疗选项以保证母婴健康？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在孕期被诊断为IIIB期玻璃细胞宫颈癌的患者应该考虑哪些治疗选项以保证母婴健康？\n\n<reference text>: 1923.Seamon, L.G., Downey, G.O., Harrison, C.R., Doss, B.& Carlson, J.W.Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于孕期被诊断为IIIB期玻璃细胞宫颈癌的患者，治疗策略需要充分平衡疾病控制和胎儿健康。以下为需要综合考虑的治疗选项：\n\n1. **新辅助化疗**：在孕期进行低毒性的化疗方案，有助于控制肿瘤的进展，帮助部分患者延长妊娠至胎儿成熟。此方法在某些案例中显示出令人鼓舞的结果。\n\n2. **延迟治疗至分娩后**：如果患者肿瘤进展缓慢且妊娠已接近足月，可以考虑延迟进行全面治疗，等到分娩后再开展化疗和放疗。\n\n3. **剖宫产后全身治疗**：若妊娠早期即可进行剖宫产分娩后立刻开展化疗联合放疗，以尽早控制癌症。\n\n4. **多学科团队管理**：包括妇科肿瘤学家、产科医生、新生儿科医生和放化疗专家的联合会诊，综合评估疾病阶段和妊娠周数，个体化选择治疗路径。\n\n这些选择需根据患者的具体病情、肿瘤位置、胎儿发育状态、患者意愿以及多学科团队的专业建议制定，确保在尽可能控制母亲疾病的基础上保护胎儿健康。"
}